Brandon Kotaniemi’s Post

How do Key Opinion Leaders drive progress in oncology? Our latest article explores the roles of Key Opinion Leaders in oncology, from leading clinical trials to shaping healthcare policy. Learn how these experts are not just advancing cancer research but also shaping policy and treatment standards across the globe - https://bit.ly/48WTGBF #konectar #KOLIdentification #Oncology #KeyOpinionLeaders #HCPs

ZDNET’s Tiernan Ray spoke with Absci Founder and CEO Sean McClain and Memorial Sloan Kettering Cancer Center's SVP of Technology Development Greg Raskin to discuss our new collaboration with MSK to co-develop cancer therapeutics using generative AI. Read the article here: https://lnkd.in/en8z4HpJ #AI #DrugDiscovery #Oncology #Biologics

If you are focused in oncology development research, please take the time to listen to the following webinar, led by one of our Drug Development Advisory Colleagues, who is the leading Oxford Professor of Experimental Oncology Dr Sarah Blagden. You will find this very insightful #oncologyresearch #Clinicresearch #qualityoutcomes

Precision Oncology Clinical Trials And Statistics 2024 - https://lnkd.in/e59pRq-C - Source: Novotech This whitepaper not only charts the evolution and achievements in precision oncology but also sets the stage for the future, emphasizing the need for continued innovation and collaboration.

Precision Oncology Market size is estimated to expand at 10.6% CAGR from 2023 to 2032. Read More: https://lnkd.in/d7PrbAkd Key Players Are Thermo Fisher Scientific, Invitae, Illumina, QIAGEN, Novartis #PrecisionOncology #CancerResearch #PersonalizedMedicine #OncologyTreatment #GenomicMedicine #PrecisionMedicine #CancerTherapeutics #TargetedTherapy #MolecularDiagnostics #Oncogenomics #TumorProfiling #CancerGenomics

Ready to navigate the complexities of phase I oncology trials? Join us for an insightful on-demand webinar with Oxford University Professor of Experimental Oncology, Dr. Sarah Blagden. Discover how meticulous planning and evaluation of clinical positioning can ensure your early phase oncology studies run smoothly and efficiently. Don’t miss out on this opportunity to learn from an expert! Watch the webinar here: How to Take an Oncology Drug to the Clinic (https://lnkd.in/e5suYhaw) #Oncology #ClinicalTrials #Webinar #HealthcareInnovation #MedicalResearch #Pharma #Biotech

This article is amazing about the future of Oncology. #oncology #pharmacy #future https://lnkd.in/gQUQUhgS

There have been a lot of advances in cancer therapy in the past few years, with a large focus on immunotherapies. It's great to also see radiopharma overcoming some of its earlier hurdles and making a prime time appearance on the precision medicine stage. #precisionmedicine #radiopharma #biotechtrends #pharmatrends #cancertherapy https://lnkd.in/ef-VcRPj

American Society of Clinical Oncology (ASCO) attendees, what were some of the most interesting things you saw at this year's conference? Please share. We'd love to know what caught your attention. In the meantime, Clinical Trials Arena put together a top 10 list of breaking research at the conference. Any significant research to add to the list? #lungcancer #cancerresearch #lungcancerawareness #asco2024 https://lnkd.in/gumpz_WX

Uncover groundbreaking oncology trial results like IRIS and BCIRG 006. Explore the unexpected findings of the DREAMM-7 trial in relapsed multiple myeloma. https://lnkd.in/e3fyvDfT